Latest Market Access News

Titomic Limited is gearing up for a strategic shift to the US with a planned redomicile in H2 2026, while clinching major contracts across aerospace, defense, and rail sectors and achieving critical certifications that underpin its manufacturing ambitions.

4DMedical has made significant strides in commercial adoption of its CT:VQ™ lung imaging technology, securing top US hospital contracts, regulatory approvals in Europe and the UK, and a major pharmaceutical partnership, all backed by strong capital raises and inclusion in the S&P/ASX 200.

Control Bionics progresses its scalable distributor-led model in North America, inks a strategic US partnership for iOS speech devices, and gains German reimbursement eligibility for NeuroNode, while managing cash flow amid NDIS delays.

Altech Batteries has won conditional approval for a €46.11 million German government grant supporting its CERENERGY® Sodium-Chloride Solid-State battery project, while shifting its Silumina AnodesTM R&D operations to Germany to enhance efficiency and cut costs.

Nimy Resources has identified significant extensions to its high-grade gallium deposit at Mons Block 3 and shipped test material to the US as part of a strategic partnership. A scoping study is underway to evaluate mining and processing economics, while regional exploration continues across multiple targets.

Nova Eye Medical reported a 23% rise in quarterly sales to US$5.8 million, driven by strong US growth and initial Chinese sales. EBITDA loss narrowed significantly, with positive operational EBITDA recorded.

Carnaby Resources has delivered a robust Pre-Feasibility Study and declared its maiden Ore Reserve at the Greater Duchess Copper Gold Project, setting sights on first production in the second half of 2026.

Sovereign Metals' March 2026 update reveals a robust DFS for its Kasiya Rutile-Graphite Project, a substantial resource upgrade, strategic offtake MOUs, and a high-value heavy rare earth by-product discovery.

Lake Resources made solid progress on the Exploitation Environmental Impact Assessment for its Kachi Lithium Brine Project, targeting approval in Q3 2026, while maintaining strong liquidity and strategic partnerships.

Atomo Diagnostics capitalises on Lumos Diagnostics’ FebriDx FDA CLIA waiver with over $2 million in new sales orders and a $3 million capital raise, expanding its global footprint and product pipeline.

Elsight’s Halo connectivity platform has gained critical approval on the U.S. Department of War’s DCMA Blue List, enabling rapid military procurement amid a historic US$75 billion drone budget surge.

Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.